Evidence map›Paper›PMID 34648123›Full record

ArticleBiological trace element research2022

Intracellular Iron Binding and Antioxidant Activity of Phytochelators.

Fredson Torres Silva, Breno Pannia Espósito

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Biological trace element research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Therapeutic potential of iron chelators in retinal vascular diseases.International journal of ophthalmology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Fredson Torres SilvaDepartment of Fundamental Chemistry, Institute of Chemistry, University of São Paulo, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0003-2891-507X
Breno Pannia EspósitoDepartment of Fundamental Chemistry, Institute of Chemistry, University of São Paulo, São Paulo, SP, Brazil. breno@iq.usp.br.ORCID http://orcid.org/0000-0002-1447-435X
Universidade de São Paulo · BR

Funding

FAPESP 2018/19684-0
6 · The paper itself

Abstract

Phytochelators have been studied as templates for designing new drugs for chelation therapy. This work evaluated key chemical and biological properties of five candidate phytochelators for iron overload diseases: maltol, mimosine, morin, tropolone, and esculetin. Intra- and extracellular iron affinity and antioxidant activity, as well as the ability to scavenge iron from holo-transferrin, were studied in physiologically relevant settings. Tropolone and mimosine (and, to a lesser extent, maltol) presented good binding capacity for iron, removing it from calcein, a high-affinity fluorescent probe. Tropolone and mimosine arrested iron-mediated oxidation of ascorbate with the same efficiency as the standard iron chelator DFO. Also, both were cell permeant and able to access labile pools of iron in HeLa and HepG2 cells. Mimosine was an effective antioxidant in cells stressed by iron and peroxide, being as efficient as the cell-permeant iron chelator deferiprone. These results reinforce the potential of those molecules, especially mimosine, as adjuvants in treatments for iron overload.

Indexed as

Iron Chelating AgentsIron OverloadAntioxidantsDeferoxamineHumansIronMimosinePyridonesTropoloneAntioxidantsDeferoxamineIronIron Chelating AgentsMimosinePyridonesTropoloneIronOverloadPhytochelatorsTransferrinTropolone

Identifiers

PMID34648123
OpenAlexW3206201183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.